SCHEMBL3886166

SCHEMBL3886166

CCN1CCc2c([nH]c3ccc(N)cc23)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.52
HTR1A P08908 1/20 0.49
DRD2 P14416 1/20 0.47
DRD1 P21728 1/20 0.47
DRD4 P21917 1/20 0.47
DRD5 P21918 1/20 0.47
GRIN2B Q13224 3/20 0.46
ACHE P22303 3/20 0.44
GRIN1 Q05586 3/20 0.44
GRIN2A Q12879 3/20 0.44
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN2C Q14957 2/20 0.44
GRIN3A Q8TCU5 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ATM Q13315 2/20 0.44
GAA P10253 1/20 0.44
RCE1 Q9Y256 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3876357 0.90 HTR1A (0.56) BAZ2BHTR1AGRIN2BACHEGRIN1
SCHEMBL21731608 0.84 MEN1 (0.55) BAZ2BHTR1ADRD2DRD1DRD4
SCHEMBL3874258 0.83 BAZ2B (0.46) BAZ2BHTR1AGRIN2BSIGMAR1MEN1
SCHEMBL3880081 0.82 KDM4E (0.64) BAZ2BDRD2DRD1DRD4DRD5
SCHEMBL3883560 0.81 BAZ2B (0.54) BAZ2BDRD2DRD1DRD5GRIN2B
SCHEMBL6369610 0.80 HTR1A (0.71) HTR1ADRD2DRD1DRD4DRD5
SCHEMBL1415364 0.79 HTR1A (0.56) HTR1AGRIN2BSIGMAR1
SCHEMBL3887465 0.79 MAPT (0.60) BAZ2BHTR1ADRD2DRD1DRD4
SCHEMBL7996548 0.78 BAZ2B (0.49) BAZ2BDRD2DRD1DRD4DRD5
SCHEMBL930105 0.78 GRIN2B (0.51) BAZ2BHTR1AGRIN2BACHEGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263609-B2 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-09-11 US disclosed
EP-1919475-B1 TETRAHYDRO- BETA-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS ESTEVE LABOR DR (ES) 2009-03-11 EP disclosed
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands HTR6, HTR5A, HTR1B BAZ2B 4267/4885HTR1A 9/4885DRD2 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.